Edition:
United Kingdom

Mrinalika Roy

Abbott wins U.S. authorization for $5 rapid COVID-19 antigen test

27 Aug 2020

Abbott Laboratories said on Wednesday it won U.S. marketing authorization for a COVID-19 portable antigen test that can deliver results within 15 minutes and will sell for $5.

U.S. says testing not needed for some exposed to COVID-19, sparking outcry

27 Aug 2020

The U.S. Centers for Disease Control and Prevention (CDC) said this week that people exposed to COVID-19 but not symptomatic may not need to be tested, shocking doctors and politicians and prompting accusations the guidance was politically motivated.

U.S. agency spells out new COVID-19 testing mandate for nursing homes

25 Aug 2020

Nursing homes in the United States will now be required to test staff for COVID-19 and offer testing to residents, the Centers for Medicare & Medicaid Services (CMS) said on Tuesday.

New York charges Teva, Allergan with insurance fraud over opioid claims

18 Aug 2020

NEW YORK New York state filed civil charges on Tuesday accusing Teva Pharmaceutical Industries Ltd and Allergan Plc with insurance fraud for downplaying the risks of their opioid painkillers to patients and doctors.

Top U.S. health official says approval of COVID vaccines unlikely before November

13 Aug 2020

Any potential COVID-19 vaccine backed by the Trump administration's "Operation Warp Speed" program is unlikely to receive a green light from regulators any earlier than November or December, given the time needed for a large-scale clinical trial, the National Institutes of Health director said on Thursday.

SmileDirectClub revenue plunges on weak demand for dental aligners

12 Aug 2020

Dental products maker SmileDirectClub Inc reported an 82% fall in quarterly revenue on Wednesday, as delayed procedures due to coronavirus-led restrictions hurt sales of its aligners, sending its shares down about 6% in extended trade.

Becton on track to make one billion syringes to help COVID-19 vaccination

06 Aug 2020

Becton Dickinson and Co said on Thursday it was on track to make 1 billion syringes in the next 12-18 months to meet demand for COVID-19 vaccination when approved, as the medical device maker reported quarterly revenue below estimates, sending its shares down nearly 9%.

AbbVie's Humira powers profit beat as COVID-19 weighs on Botox sales

31 Jul 2020

AbbVie Inc on Friday posted a quarterly adjusted profit above estimates as robust sales of its blockbuster arthritis treatment, Humira, helped cushion weak demand for its aesthetic drugs, including Botox, due to the COVID-19 pandemic.

World News